Abstract. N-linked protein glycosylation is involved in various biological processes, such as protein quality control and adhesion or signaling among cells. The loss of ancestrally conserved N-glycosylation sites may result in the evolution of protein structure and function. In the present study, a mouse glycoproteome dataset and mammalian proteome data were assessed to identify 40 ancestral N-glycosylation sites in 37 proteins that disappeared during human evolution since the last common ancestor of the Euarchonta (primates and treeshrews). The results showed that each of the human proteins, CELSR1, ST3GAL5 and VSIG10, lost an ancestrally conserved N-glycosylation site following human-chimpanzee divergence. Notably, CELSR1 and ST3GAL5 are crucial for normal development and function of the mammalian nervous system, suggesting an association with the evolution of human cognitive function. Thus, the lost ancestrally conserved N-glycosylation sites identified in the present study may be useful targets for functional analyses to identify molecular changes linked with the evolution of human phenotypes.
Introduction
N-linked glycosylation is a well-studied protein post-translational modification (PTM) that occurs at the Asn residue in the consensus motif Asn-X-Ser/Thr, where X is any amino acid except Pro (1) . N-glycosylation modulates the folding, stability, trafficking and turnover of proteins, especially those of secreted or membrane attached proteins, which are involved in various cell processes such as cell-cell interaction or intracellular signaling (2) (3) (4) . As N-glycosylation is involved in important cell functions, numerous N-glycosylation sites are evolutionarily conserved (5) .
We hypothesized that the losses of certain ancestrally conserved N-glycosylation sites during evolution may have been involved in the acquisition of novel human phenotypes. The loss of N-glycosylation often disrupts the normal function of proteins due to improper folding, trafficking, or activity of the proteins (6, 7) . A proteome-wide analysis of non-synonymous single-nucleotide variations in the N-glycosylation motifs of human proteins revealed that 259 sites were lost because of missense substitutions, some of which are involved in various diseases (8) . Although loss of a glycosylation modification usually results in disadvantageous phenotypes, some losses may be beneficial and fixed in humans during evolution. For example, loss of the glycan moiety N-glycolylneuraminic acid from cell surface proteins by the inactivation of the CMAH gene, encoding CMP-Nacetylneuraminic acid hydroxylase, was associated with the evolution of resistance to a certain type of malaria in early humans, although this loss subsequently led to susceptibility to other pathogens (9, 10) .
A large number of N-glycosylation sites identified from non-human animals and a suitable bioinformatics procedure are necessary to identify cases where ancestrally conserved N-glycosylation sites were lost during human evolution. An ideal dataset for this analysis is the N-glycoproteome data obtained from mouse tissues and plasma using high-throughput mass spectrometry (11) . Previously, a bioinformatics method was used to identify novel gains of N-glycosylation sites during human evolution (12) . In the present study, the procedure involved a simple modification to identify losses of ancestral N-glycosylated Asn residues during human evolution following the divergence of the Euarchonta lineage from the Glires lineage. Additionally, a comprehensive literature survey was performed to infer the possible functional outcomes of these changes, especially for human-specific losses.
Materials and methods
Mouse N-glycosylation site data. For the N-linked glycosylation dataset from a non-human proteome, we initially tested mouse data in the UniProt database. However, there were only 419 experimentally verified mouse N-glycosylation sites (as of December 20, 2013) . Therefore, mouse N-glycoproteome dataset from Zielinska et al was utilized (11) . This dataset consisted of 6,367 N-linked glycosylation sites in
Computational screening for candidate lost N-glycosylation sites. The total number of mouse N-glycosylation sites in the data set from Zielinska et al was 6,367 (11) . The 'multiz100way' alignment data, containing 57,289 alignment sets, were analyzed to identify human and other mammalian orthologs of each of the mouse N-glycosylated proteins (Fig. 1) . Ad hoc Perl scripts were used to analyze the data. There were 1,658 orthologous protein datasets containing human and mouse protein sequences. This dataset covered 4,633 mouse N-glycosylation sites. From each dataset, the mammalian sequences were extracted and realigned using MUSCLE (http://www.drive5.com/muscle) (15) .
Each of the positions that aligned with a mouse N-glycosylation site was examined using ad hoc Perl scripts. Sites that were conserved in humans, where the human protein had a consensus N-glycosylation motif, were discarded. Sites where ≥30% non-Euarchonta mammals did not have an Asn residue, indicating a frequent loss in these species, were also discarded. A total of 47 sites in 43 protein alignments were obtained after this computational screening step.
Manual inspection to select lost N-glycosylated Asn residues in the human lineage. As a final step, we manually scrutinized the 47 candidates to identify highly probable instances of N-glycosylation site loss during evolution of the human lineage. In each dataset, the species that had many gaps compared to other mammals were removed. When the mouse sequence utilized from Zielinska et al (11) differed from that of the UCSC database by at least three residues, the case was discarded as the orthology of the aligned proteins could not be guaranteed. We also discarded cases in which the mouse N-glycosylation site did not conform to the canonical sequence, or cases showing low sequence conservation among mammals.
Finally, 40 ancestral N-glycosylation sites in 37 proteins were identified to be lost during human evolution. The human and mouse protein sequences in the UCSC alignment were mapped to UniProt database sequences to utilize the UniProt annotation record. We examined the multiple sequence alignment and the mammalian phylogenetic tree to infer the timing of the loss of the N-glycosylated Asn residue.
Results and Discussion
Identification of N-glycosylation sites lost during human evolution and timing of loss. We applied a bioinformatics procedure previously developed to identify novel N-glycosylation sites during human evolution, with modifications (12). Initially, there were 6,367 experimentally identified mouse N-glycosylation sites from 2,352 proteins in the dataset from Zielinska et al (11) and 57,289 orthologous protein sequence alignments from 62 mammalian species extracted from the UCSC 'multiz100way' data (13, 14) . These data were analyzed to collect N-glycosylation sites lost during human evolution after the Euarchonta (primates and treeshrews) diverged from the Glires (rodents and rabbits).
As a result, 40 N-glycosylation sites in 37 proteins were identified to have been lost during human evolution (Table Ι) . Of the 37 proteins, three proteins encoded by the ICAM1, LRP2 and MASP2 genes had each lost two N-glycosylation sites (nos. 13 and 14 for ICAM1, 23 and 24 for LRP2, and 27 and 28 for MASP2), and the remaining 34 proteins had lost one site each. Fig. 2 shows the number of N-glycosylation sites that have been lost in each common ancestor along the human lineage: humans, three; humans and chimpanzees, two; African great apes, six; great apes, one; apes, two; catarrhines, three; simians, 19; primates, three; and Euarchonta, one.
Of the 37 N-glycosylation sites that were lost in the human lineage since the divergence of the Euarchonta and the Glires, three events occurred in human proteins after the divergence of humans and chimpanzees (Table I , nos. 7, 33 and 40 and Fig. 3 ). The residue positions for these human-specific losses are Ser-2140 in cadherin EGF LAG seven-pass G-type receptor 1 encoded by the CELSR1 gene, Lys-280 in lactosylceramide α-2,3-sialyltransferase encoded by the ST3GAL5 gene, and Ile-100 in the V-set and immunoglobulin domain-containing protein 10 encoded by the VSIG10 gene.
Human-specific loss of N-glycosylation at the amino acid position 2140 of CELSR1. The human cadherin EGF LAG seven-pass G-type receptor 1 or CELSR1, encoded by the CELSR1 gene, is a heavily glycosylated protein with 20 glycosylation sites (http://www.uniprot.org/uniprot/Q9NYQ6). Sequence comparison revealed that an ancestrally conserved glycosylation site at position 2140 was altered from Asn to Ser in humans following the human-chimpanzee divergence (Fig. 3A) . The other mammals examined have a conserved Asn residue, conforming to the N-glycosylation motif consensus.
The CELSR1 protein is a member of the flamingo cadherin protein family, which are proteins located at the plasma membrane with seven transmembrane domains (16, 17) . It has nine cadherin domains, seven epidermal growth factor-like repeats and two laminin A G-type repeats. This gene is highly expressed during mouse embryonic development, especially in the central nervous system (16, 17) . Mutations in this protein were reported to cause neural tube defects and caudal agenesis in humans (18, 19) . Therefore, CELSR1 may play an important role in contact-mediated signaling during nervous system formation in early embryogenesis. CELSR1 also plays an important role in the development of other organs, such as lung branching morphogenesis (20) , intraluminal valve formation in lymphatic vessels (21) , and hair follicle polarization and orientation (22) .
Therefore, changes in the CELSR1 protein may be involved in the evolution of the nervous system, lung, lymphatic system, or hair patterns. However, a probable direct phenotypic consequence of the loss of the N-glycosylation site at position 2140 in humans remains to be determined.
Human-specific loss of N-glycosylation at the amino acid position 280 of ST3GAL5. The human lactosylceramide α-2,3-sialyltransferase, encoded by the ST3GAL5 gene, which is also known as ganglioside GM3 synthase or sialyltransferase 9 (SIAT9), has three N-glycosylation sites (http://www.uniprot. org/uniprot/Q9UNP4). A sequence comparison revealed that the human protein lost a conserved N-glycosylation site at 280 (Asn to Lys) following the human-chimpanzee divergence (Fig. 3B) . All of the other mammals analyzed, except three, have the N-glycosylation consensus sequence at this site. A loss of the N-glycosylation consensus motif was also identified in guinea pigs, chinchillas, and brush-tailed rats (also known as degus), which have a Gly residue instead of Asn at the corresponding position. The three species belong to the rodent clade Caviomorpha (23) , suggesting that the Asn-to-Gly change occurred in an ancestor of the three mammals.
The ST3GAL5 gene encodes a sialyltransferase, a type II membrane protein that catalyzes the formation of GM3, a glycosphingolipid enriched in neural tissue, by adding sialic acid to lactosylceramide (24, 25) . GM3 is known to participate in the induction of cell differentiation, modulation of cell proliferation, and integrin-mediated cell adhesion.
Mutations in this gene are associated with several neurological disorders, such as Amish infantile epilepsy syndrome (26), Salt and Pepper syndrome characterized by severe intellectual disability, epilepsy, scoliosis, choreoathetosis, dysmorphic facial features and altered dermal pigmentation (25) , or disruption of the structural integrity and function of cochlear hair cells (27) . Therefore, the ST3GAL5 enzyme is crucial for normal neural development and function. The loss of an ancestrally conserved N-glycosylation site may be associated with a novel phenotype in the nervous system and function in humans, which may be demonstrated by molecular functional analysis.
Human-specific loss of N-glycosylation at position 100 of VSIG10. The VSIG10 gene encodes for V-set and immunoglobulin domain-containing protein 10. The human VSIG10 protein has nine N-glycosylation sites (http://www.uniprot. org/uniprot/Q8N0Z9). In the present study, we found that this protein lost an ancestrally conserved site at position 121, specifically, an Asn-to-Ile mutation abolished the N-glycosylation consensus (Fig. 3C) . Of note, the consensus motif was also independently lost in squirrels and chinchillas. VSIG10 is a single-pass type I membrane protein containing a V-set domain, two immunoglobulin domains, and an I-set domain, which is present in cell adhesion molecules. No known molecular or biological function of VSIG10 has been reported. Human-specific losses of ancestral N-glycosylation sites. The ancestral N-glycosylation sites and the surrounding regions of (A) CELSR1 Ser-2140, (B) ST3GAL5 Lys-280 and (C) VSIG10 Ile-100 are presented. The ancestral N-glycosylation consensus sequences are highlighted in grey, and corresponding sequences that lost the consensus, in black. The adjacent conserved N-glycosylation site Asn-108 in VSIG10 is indicated by plus signs (+++). The residues that are identical to those in the human sequence are indicated by dots (.). Dashes (-) denote alignment gaps. In some species, the sequences were not determined. hum, humans; hac, humans and chimpanzees; aga, African great apes; gra, great apes; ape, apes; cat, catarrhines; sim, simians; pri, primates; eua, Euarchonta; gli, Glires; lau, Laurasiatheria; afr, Afrotheria; xen, Xenarthra; mar, Marsupialia; and mon, Monotremata.
In conclusion, we have identified 40 cases for loss of ancestrally conserved N-glycosylation sites, three of which are human-specific. Two human-specific losses occurred in the CELSR1 and ST3GAL5 proteins, which play indispensable roles in the normal development and function of the nervous systems. This finding suggests that the loss of N-glycosylation sites in these proteins may be associated with the evolution of human cognitive function. We suggest that a loss of ancestrally conserved N-glycosylation sites may result in the evolution of novel phenotypes, and the cases identified in the present study may serve as immediate targets for functional analyses to elucidate the molecular basis for an explanation of human phenotype evolution.
